Heidelberg, Germany

Ulrich Raeth

This inventor holds 2 USPTO granted patents. Top assignee: Knoll Aktiengesellschaft. Active years: 1992-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrich Raeth. Retrieved from https://idiyas.com/inventor/ulrich-raeth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1992-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ulrich Raeth: Innovator in Drug Preparation

Introduction

Ulrich Raeth is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of drugs for medical use. With a total of 2 patents, his work has had a meaningful impact on therapeutic practices.

Latest Patents

Raeth's latest patents focus on the use of TNF (Tumor Necrosis Factor) and LT (Lymphotoxin) for the preparation of drugs. These compounds are utilized for the prophylaxis and therapy of effusions in body cavities. His innovative approach aims to enhance treatment options for patients suffering from various medical conditions.

Career Highlights

Throughout his career, Ulrich Raeth has been associated with Knoll Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has been instrumental in advancing drug development processes and improving patient outcomes.

Collaborations

Raeth has collaborated with esteemed colleagues such as Manfred Kaufmann and Erich Schlick. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ulrich Raeth's contributions to drug preparation and his innovative use of TNF and LT highlight his importance in the pharmaceutical field. His work continues to influence therapeutic practices and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…